{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:47:45Z","timestamp":1785764865286,"version":"3.56.0"},"reference-count":45,"publisher":"Royal College of Psychiatrists","issue":"3","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["BJPsych Bull"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Clozapine remains the gold standard intervention for treatment-resistant schizophrenia; however, it remains underused, especially for some minority groups. A significant impediment is concern about propensity to neutropenia. The aim of this article is to provide an update on current knowledge relating to: the pattern and incidence of severe blood dyscrasias; the effectiveness of current monitoring regimes in reducing harm; the mechanisms of and the distinctions between clozapine-induced neutropenia and agranulocytosis; benign ethnic neutropenia; and changes to the monitoring thresholds in the USA and other international variations. These all have implications for the practical use of clozapine; specifically, how barriers to initiating, maintaining and restarting clozapine can be understood and in many cases overcome, especially for patients from minority groups, potentially with simpler approaches than the use of lithium or G-CSF.<\/jats:p>","DOI":"10.1192\/bjb.2024.38","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T09:53:27Z","timestamp":1717408407000},"page":"163-168","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":7,"title":["Understanding clozapine-related blood dyscrasias. Developments, genetics, ethnicity and disparity: it's a CIN"],"prefix":"10.1192","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7254-6307","authenticated-orcid":false,"given":"Edward","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6617-0289","authenticated-orcid":false,"given":"Sophie","family":"Legge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Casetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-0073","authenticated-orcid":false,"given":"Eromona","family":"Whiskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1352-4017","authenticated-orcid":false,"given":"Ebenezer","family":"Oloyede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"S205646942400038X_ref23","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291719000369"},{"key":"S205646942400038X_ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009717"},{"key":"S205646942400038X_ref27","doi-asserted-by":"publisher","DOI":"10.1053\/lc.1999.v133.a94931"},{"key":"S205646942400038X_ref32","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2023.08.002","article-title":"Clozapine and neutrophil response in patients of African descent: a six-month, multinational, prospective, open-label clinical trial","author":"Kelly","year":"2023","journal-title":"Schizophr Res"},{"key":"S205646942400038X_ref12","doi-asserted-by":"publisher","DOI":"10.1017\/S204579602200066X"},{"key":"S205646942400038X_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.06.003"},{"key":"S205646942400038X_ref14","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.187"},{"key":"S205646942400038X_ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-04851-4"},{"key":"S205646942400038X_ref38","unstructured":"38 Royal College of Psychiatrists. Equality Action Plan. RCPsych, 2021."},{"key":"S205646942400038X_ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0957154X07070335"},{"key":"S205646942400038X_ref31","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa208"},{"key":"S205646942400038X_ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013297"},{"key":"S205646942400038X_ref7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12888-023-04902-w","article-title":"The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia","volume":"23","author":"Oloyede","year":"2023","journal-title":"BMC Psychiatry"},{"key":"S205646942400038X_ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1035-5"},{"key":"S205646942400038X_ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01322-w"},{"key":"S205646942400038X_ref20","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12898"},{"key":"S205646942400038X_ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-022-00232-0"},{"key":"S205646942400038X_ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-017-0172-1"},{"key":"S205646942400038X_ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-022-02257-3"},{"key":"S205646942400038X_ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-021-03514-6"},{"key":"S205646942400038X_ref41","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000715"},{"key":"S205646942400038X_ref39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12888-020-02592-2","article-title":"Clozapine rechallenge and initiation despite neutropenia: a practical, step-by-step guide","volume":"20","author":"Silva","year":"2020","journal-title":"BMC Psychiatry"},{"key":"S205646942400038X_ref5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1192\/bjb.2018.67","article-title":"Barriers to using clozapine in treatment-resistant schizophrenia: systematic review","volume":"43","author":"Farooq","year":"2019","journal-title":"BJPsych Bull"},{"key":"S205646942400038X_ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(22)00188-2"},{"key":"S205646942400038X_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.09.024"},{"key":"S205646942400038X_ref1","article-title":"A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia","author":"Dong","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"S205646942400038X_ref22","doi-asserted-by":"publisher","DOI":"10.1177\/0004867419833166"},{"key":"S205646942400038X_ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1167-0"},{"key":"S205646942400038X_ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0335-7"},{"key":"S205646942400038X_ref36","doi-asserted-by":"publisher","DOI":"10.1177\/20451253211015070"},{"key":"S205646942400038X_ref19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000646"},{"key":"S205646942400038X_ref2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1192\/bjp.bp.111.105833","article-title":"Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation","volume":"201","author":"Howes","year":"2012","journal-title":"Br J Psychiatry"},{"key":"S205646942400038X_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(14)70245-7"},{"key":"S205646942400038X_ref43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/schbul\/sbab006","article-title":"There is life after the UK clozapine central non-rechallenge database","volume":"47","author":"Oloyede","year":"2021","journal-title":"Schizophr Bull"},{"key":"S205646942400038X_ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-023-00982-6"},{"key":"S205646942400038X_ref44","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000258"},{"key":"S205646942400038X_ref28","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-7-200704030-00004"},{"key":"S205646942400038X_ref11","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.16m11152"},{"key":"S205646942400038X_ref40","unstructured":"40 Royal College of Psychiatrists. The Role of Genetic Testing in Mental Health Settings. College Report CR237. RCPsych, 2023."},{"key":"S205646942400038X_ref26","volume-title":"Interactive Drug Analysis Profile: Clozapine","year":"2023"},{"key":"S205646942400038X_ref45","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20699"},{"key":"S205646942400038X_ref37","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2019.267"},{"key":"S205646942400038X_ref3","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13280"},{"key":"S205646942400038X_ref10","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/bmj.313.7067.1262a","article-title":"Reply from Clozaril Patient Monitoring Service","volume":"313","author":"O'Sullivan","year":"1996","journal-title":"BMJ"},{"key":"S205646942400038X_ref30","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008600"}],"container-title":["BJPsych Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S205646942400038X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T06:00:01Z","timestamp":1750140001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S205646942400038X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S205646942400038X"],"URL":"https:\/\/doi.org\/10.1192\/bjb.2024.38","relation":{},"ISSN":["2056-4694","2056-4708"],"issn-type":[{"value":"2056-4694","type":"print"},{"value":"2056-4708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"\u00a9 The Author(s), 2024. Published by Cambridge University Press on behalf of Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}